Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning

C L Patti1, S R Kameda, R C Carvalho

  • 1Department of Pharmacology, Universidade Federal de São Paulo, Rua Botucatu, 862-Ed. Leal Prado, 04023-062 São Paulo, Brazil.

Psychopharmacology
|December 13, 2005
PubMed
Abstract

Insights

Morphine impairs memory retrieval in mice, potentially due to state-dependent learning. This memory deficit, induced by morphine before training, can be reversed by administering morphine before testing.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Morphine's amnesic effects may involve nociception, anxiety, or locomotion.
  • State-dependent learning is a potential factor in morphine-induced amnesia.

Purpose of the Study:

  • To investigate morphine's effects on learning, memory, anxiety, and locomotion in mice using a plus-maze discriminative avoidance task (DAT).
  • To explore the role of state-dependent learning in morphine's impact on memory.

Main Methods:

  • Utilized a modified elevated plus-maze for the discriminative avoidance task (DAT) with light and noise as aversive stimuli.
  • Administered morphine (5-20 mg/kg) before training or testing to assess acquisition, retrieval, anxiety, and locomotion.

Main Results:

  • Pretraining morphine induced memory retrieval deficits but not acquisition deficits.
  • Pretest morphine (5-10 mg/kg) reversed the retrieval deficits.
  • Morphine caused hypolocomotion independently of memory effects.
  • Morphine did not alter anxiety-like behavior during training.

Conclusions:

  • Morphine administration before training causes retrieval deficits in the DAT, possibly linked to state-dependent learning.
  • The memory deficits and their reversal by pretest morphine were not associated with anxiety or locomotion changes.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...